Kaplan–Meier DFS analysis showed that high expression of HNRNPA2B1 was a risk factor for the progression of ACC, GBMLGG, KIRP, CESC, LIHC, COAD, and KIPAN, as well as a favorable factor for resistance to OV progression. This evidence concerns the gene HNRNPA2B1 and adrenal cortex carcinoma.